Clinical effects of laparotomy with perioperative continuous peritoneal lavage and postoperative hemofiltration in patients with severe acute pancreatitis

World Journal of Emergency Surgery

Volumn 4, Issue 1, 2009, Pages

  Caronna, Roberto ^a   Benedetti, Michele ^a   Morelli, Andrea ^a   Rocco, Monica ^a   Diana, Loretta ^b   Prezioso, Giampaolo ^a   Cardi, Maurizio ^a   Schiratti, Monica ^a   Martino, Gabriele ^a   Fanello, Gianfranco ^a   Papini, Federica ^a   Farelli, Francesco ^a   Meniconi, Roberto L ^a   Marengo, Michele ^a   Dinatale, Giuseppe ^a   Chirletti, Piero ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952641490     PISSN: None     EISSN: 17497922     Source Type: Journal    
DOI: 10.1186/1749-7922-4-45     Document Type: Article

References (43)

1. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg 1997, 21:130-135. 10.1007/s002689900204, 8995067.
2. Dugernier T, Starkel P, Laterre PF, Reynaert MS. Severe acute pancreatitis: pathophysiologic mechanisms underlying pancreatic necrosis and remote organ damage. Acta Gastroenterol Belg 1996, 59:178-185.
3. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000, 190(2):117-125. 10.1002/(SICI)1096-9896(200002)190:2<117::AID-PATH494>3.0.CO;2-K, 10657008.
4. Brady M, Christmas S, Sutton R, Neoptolemos JP, Slavin J. Cytokines and acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999, 13(2):265-289. 10.1053/bega.1999.0024, 11030606.
5. Denham W, Norman J. The potential role of therapeutic cytokine manipulation in acute pancreatitis. Surg Clin North Am 1999, 79(4):767-781. 10.1016/S0039-6109(05)70042-6, 10470326.
6. Giroic BP. Pancreatitis cytokines and SIRS: déià vu all over again?. Crit Care Med 1999, 27(4):680-681. 10.1097/00003246-199904000-00007, 10321647.
7. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998, 175(1):76-83. 10.1016/S0002-9610(97)00240-7, 9445247.
8. Hirota M, Nozawa F, Okabe A, Shibata M, Beppu T, Shimada S, Egami H, Yamaguchi Y, Ikei S, Okajima T, Okamoto K, Ogawa M. Relationship between plasma cytokine concentration and multiple organ failure in patients with acute pancreatitis. Pancreas 2000, 21(2):141-146. 10.1097/00006676-200008000-00006, 10975707.
9. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000, 47(4):546-552. 10.1136/gut.47.4.546, 10986216.
10. Osman MO, Jensen SL. Acute pancreatitis: the pathophysiological role of cytokines and integrins. New trends for treatment?. Dig Surg 1999, 16(5):347-362. 10.1159/000018746, 10567792.
11. Schmid RM, Adler G. Cytokines in acute pancreatitis-new pathophysiological concepts evolve. Eur J Gastroenterol Hepatol 1999, 11(2):125-127. 10.1097/00042737-199902000-00012, 10102222.
12. Schobersberger W, Wiedermann F, Tilz GP, Fuchs D. Predictive value of cytokines during acute severe pancreatitis. Crit Care Med 2000, 28(7):2673-2674. 10.1097/00003246-200007000-00094, 10921625.
13. Wang H, Li WQ, Zhou W, Li N, Li JS. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 2003, 9(9):2096-2099.
14. Bellomo R. Continuous hemofiltration as blood purification in sepsis. New Horiz 1995, 3:732-737.
15. Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995, 48:1563-1570. 10.1038/ki.1995.448, 8544415.
16. Lonnemann G, Linnenweber S, Burg M, Koch KM. Transfer of endogenous pyrogens across artificial membranes?. Kidney Int Suppl 1998, 66:S43-S46.
17. Pupelis G, Plaudis H, Grigane A, Zeiza K, Purmalis G. Continuous veno-venous haemofiltration in the treatment of severe acute pancreatitis: 6-year experience. HPB (Oxford) 2007, 9(4):295-301. 2215400, 18345308.
18. Mikami Y, Takeda K, Shibuya K, Qiu-Feng H, Egawa S, Sunamura M, Matsuno S. Peritoneal inflammatory cells in acute pancreatitis: Relationship of infiltration dynamics and cytokine production with severity of illness. Surgery 2002, 132(1):86-92. 10.1067/msy.2002.125171, 12110800.
19. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: characteristics of a new subgroup. Pancreas 2001, 22(3):274-278. 10.1097/00006676-200104000-00008, 11291929.
20. Beger HG, Rau BM. Severe acute pancreatitis: clinical course and management. World J Gastroenterol 2007, 13(38):5043-5051.
21. Rau BM, Bothe A, Kron M, Beger HS. Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis. Clin Gastroenterol Hepatol 2006, 4:1053-1061. 10.1016/j.cgh.2006.05.030, 16843734.
22. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000, 47:546-552. 10.1136/gut.47.4.546, 1728074, 10986216.
23. Ogawa M. Acute pancreatitis and cytokines: 'second attack' by septic complication leads to organ failure. Pancreas 1998, 16:312-315. 10.1097/00006676-199804000-00017, 9548672.
24. Wu XN. Current concept of pathogenesis of severe acute pancreatitis. World J Gastroenterol 2000, 6:32-36.
25. Wrobleski DM, Barth MM, Oyen LJ. Necrotizing pancreatitis: pathophysiology, diagnosis, and acute care management. AACN Clin Issues 1999, 10:464-477.
26. Zhao H, Chen JW, Zhou YK, Zhou XF, Li PY. Influence of platelet activating factor on expression of adhesion molecules in experimental pancreatitis. World J Gastroenterol 2003, 9:338-341.
27. Zhang Q, Ni Q, Cai D, Zhang Y, Zhang N, Hou L. Mechanisms of multiple organ damages in acute necrotizing pancreatitis. Chin Med J 2001, 114:738-742.
28. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998, 175:76-83. 10.1016/S0002-9610(97)00240-7, 9445247.
29. Uomo G, Pezzilli R, Gabbrielli A, Castoldi L, Zerbi A, Frulloni L, De Rai P, Cavallini G, Di Carlo V, . ProInf-AISP Study Group Diagnostic assessment and outcome of acute pancreatitis in Italy: results of a prospective multicentre study. ProInf-AISP: Progetto informatizzato pancreatite acuta, Associazione Italiana Studio Pancreas, phase II. Dig Liver Dis 2007, 39(9):829-837. 10.1016/j.dld.2007.05.009, 17625994, ProInf-AISP Study Group.
30. Bradley EL. A clinically based classification system for acute pancreatitis. Arch Surg 1993, 128:586-590.
31. Balthazar EJ. Acute pancreatitis: assessment of severity with clinical anc CT evaluation. Radiology 2002, 223(3):603-613. 10.1148/radiol.2233010680, 12034923.
32. Pezzilli R, Uomo G, Gabbrielli A, Zerbi A, Frulloni L, De Rai P, Castoldi L, Cavallini G, Di Carlo V, . ProInf-AISP Study Group A prospective multicentre survey on the treatment of acute pancreatitis in Italy. Dig Liver Dis 2007, 39(9):838-846. 10.1016/j.dld.2007.05.014, 17602904, ProInf-AISP Study Group.
33. Wu XZ. Therapy of acute severe pancreatitis awaits further improvement. World J Gastroenterol 1998, 4:285-286.
34. Grootendorst AF, van Bommel EF. The role of hemofiltration in the critically-ill intensive care unit patient: present and future. Blood Purif 1993, 11:209-223. 10.1159/000170118, 8297563.
35. Hirasawa H, Sugai T, Ohtake Y, Oda S, Matsuda K, Kitamura N. Blood purification for prevention and treatment of multiple organ failure. World J Surg 1996, 20:482-486. 10.1007/s002689900076, 8662139.
36. Bellomo R, Baldwin I, Cole L, Ronco C. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int Suppl 1998, 66:S182-S185.
37. Yekebas EF, Treede H, Knoefel WT, Bloechle C, Fink E, Izbicki JR. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg 1999, 229:514-522. 10.1097/00000658-199904000-00010, 1191737, 10203084.
38. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993, 21:522-526. 10.1097/00003246-199304000-00011, 8472571.
39. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999, 27:1848-1855. 10.1097/00003246-199909000-00024, 10507609.
40. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl 1999, 72:S84-S87. 10.1046/j.1523-1755.56.s72.8.x, 10560813.
41. Pederzoli P, Bassi C, Vesentini S, Girelli R, Cavallini G, Falconi M, Nifosi F, Riela A, Dagradi A. Retroperitoneal and peritoneal drainage and lavage in the treatment of severe necrotizing pancreatitis. Surg Gynecol Obstet 1990, 170:197-203.
42. Caronna R, Diana L, Di Giovannandrea R, Campedelli P, Catinelli S, Nofroni I, Sibio S, Chirletti P. Gabexate Mesilate (FOY) inhibition of amylase and phospholipase A2 activity in sow pancreatic juice. J Invest Surg 2003, 16:345-351.
43. Caronna, Diana L, Nofroni I, Sibio S, Sammartino P, Cardi M, Catinelli S, Chirletti P. Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Dig Dis Sci 2005, 50(5):868-873. 10.1007/s10620-005-2655-0, 15906759.